HBK Investments’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-18,400
Closed -$711K 1132
2019
Q1
$711K Buy
18,400
+4,584
+33% +$155K 0.01% 747
2018
Q4
$394K Sell
13,816
-1,184
-8% -$37.6K ﹤0.01% 960
2018
Q3
$587K Buy
+15,000
New +$554K ﹤0.01% 889
2018
Q1
Sell
-93,600
Closed -$2.22M 1183
2017
Q4
$2.22M Buy
93,600
+3,043
+3% +$76.7K 0.02% 424
2017
Q3
$2.55M Sell
90,557
-36,742
-29% -$1.12M 0.02% 393
2017
Q2
$4.1M Buy
127,299
+27,799
+28% +$847K 0.03% 275
2017
Q1
$2.81M Buy
99,500
+17,400
+21% +$462K 0.02% 278
2016
Q4
$1.99M Buy
82,100
+31,200
+61% +$766K 0.02% 341
2016
Q3
$1.21M Buy
+50,900
New +$1.11M 0.01% 475
2014
Q4
Sell
-10,200
Closed -$241K 1169
2014
Q3
$241K Sell
10,200
-25,979
-72% -$739K ﹤0.01% 874
2014
Q2
$1.13M Sell
36,179
-2,821
-7% -$81.3K 0.02% 485
2014
Q1
$1.24M Buy
+39,000
New +$1.29M 0.02% 421

Other funds holding CSII

HBK Investments's CSII Position: Q2 2019 in Review

HBK Investments sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2019, closing a stake of 18,400 shares — an estimated $711K sold.

HBK Investments first reported a position in CSII in Q1 2014 and held it in 12 quarters. The position peaked at $4.1M in Q2 2017. 190 funds tracked by Wall St. Rank hold CSII as of Q2 2019.

  • HBK Investments reported no remaining Cardiovascular Systems, Inc. position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 18,400 Cardiovascular Systems, Inc. shares in Q2 2019, an estimated $711K.
  • HBK Investments first reported a position in Cardiovascular Systems, Inc. in Q1 2014 and held it in 12 quarters.
  • HBK Investments's Cardiovascular Systems, Inc. position peaked at $4.1M in Q2 2017.
  • 190 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.